Past Events
Covid-19 Biopharma Webconference
April 6, 2020
In order to inform our community and capture the remarkable talents and ability to impact the current situation, Longwood hosted a one-day complimentary webconference on April 6, 2020 with extraordinary thought leaders to address how the industry can come together and help in the fight against COVID-19. Speakers included Massachusetts Governor Baker, FDA CDER Director Janet Woodcock, Congressman Joe Kennedy III, and heads of research and development from many of the biopharmaceutical companies leading the fight regarding testing, treatment, and vaccines for COVID-19. These thought leaders included Moderna CEO Stéphane Bancel, Regeneron CSO George Yancopoulos, Merck Chief Patient Officer and former CDC Director Julie Gerberding, Johnson & Johnson Head of R&D Mathai Mammen, Pfizer CSO and President of Worldwide Research, Development and Medical Mikael Dolsten, Brigham Health President Betsy Nabel, Dana-Farber CEO Laurie Glimcher, Alnylam CEO John Maraganore, Takeda Head of R&D Andy Plump, among others. Speakers discussed approaches to fighting COVID-19 on a biomedical front as well as addressing healthcare, economic, and patient-centric concerns. Possibilities, timelines, and hurdles regarding vaccines, treatments, and testing were discussed. The executives agreed on the necessity of partnerships and collaboration in order to work towards a significant resolution to the pandemic.
Panels
.png)
Agenda
7:30 am
Longwood Fund Introduction
Christoph Westphal, General Partner, Longwood Fund
7:40 am
Healthcare Priorities for the Rest of 2020
Wyc Grousbeck, CEO & Principal Owner, Boston Celtics
Marc Lipsitch, Professor, Epidemiology, Harvard
John Maraganore, CEO, Alnylam
Maria Rivas, CMO, Merck KGaA
Moderator: Christoph Westphal, General Partner, Longwood Fund
8:20 am
Industry, Hospitals, and Academia: Impact of COVID-19
Bob Coughlin, CEO, MassBIO
Laurie Glimcher, CEO, Dana-Farber Cancer Institute
Sandra Fenwick, CEO, Boston Children's Hospital
Betsy Nabel, President, Brigham Health
Tyler Jacks, Director, MIT Koch Institute
Moderator: David Steinberg, General Partner, Longwood Fund
9:05 am
Moderated Keynote
Congressman Joe Kennedy III (Candidate, US Senate)
Moderator: Christoph Westphal, General Partner, Longwood Fund
9:30 am
Moderated Keynote
Governor Charlie Baker
Moderator: Christoph Westphal, General Partner, Longwood Fund
10:00 am
Weathering the COVID-19 Storm: Perspectives from China, Europe, and US Frontline
Jeff Capello, CFO, Biogen
Alex Harding, Internal Medicine Physician, Massachusetts General Hospital
Carolyn Ng, Managing Director, Vertex Ventures HC
Edward Hu, Co-CEO, WuXi
Nikolaus Rajewsky, MDC, Berlin and 3dgene
Yi Shi, Managing Director, Lilly Asia Ventures
Moderator: David Steinberg, General Partner, Longwood Fund
10:30 am
Novel Therapeutics and Vaccines for COVID-19
Stéphane Bancel, CEO, Moderna
Mathai Mammen, Global Head, R&D, Johnson & Johnson
George Scangos, CEO, Vir
Rajeev Vekayya, President, Vaccines, Takeda
George Yancopoulos, CSO, Regeneron
Moderator: Christoph Westphal, General Partner, Longwood Fund
11:15 am
Repurposing Products in the Pipeline for the Treatment of COVID-19
Diana Brainard, SVP, HIV & Emerging Viruses, Gilead
Gavin MacBeath, CSO, TScan Therapeutics
Stefan Oelrich, CEO, Bayer Pharmaceuticals
John Orloff, EVP, Head, R&D, Alexion
Peter Pertel, Global Translational Medicine Head, Respiratory & Infectious Diseases, NIBR
Moderator: Lea Hachigian, Principal, Longwood Fund
12:00 pm
Moderated Keynote
Janet Woodcock, Director, Center for Drug Evaluation and Research, FDA
Moderator: Christoph Westphal, General Partner, Longwood Fund
12:30 pm
Patients at the Center
José Baselga, EVP, R&D, Oncology, AstraZeneca
Julie Gerberding, Chief Patient Officer, Merck & Co.; former Director, CDC
Andy Plump, President, R&D, Takeda
John Sculley, former CEO, Pepsi/Apple
Janet Woodcock, Director, Center for Drug Evaluation and Research, FDA
Moderator: Christoph Westphal, General Partner, Longwood Fund
1:15 pm
Expediting Diagnostics, Tests, and Supplies
Steve Elledge, Harvard Medical School, Lasker Award, TScan, VirScan
Michael Mina, Center for Communicable Disease Dynamics, Harvard Medical School
Prahlad Singh, CEO, PerkinElmer
Mark Stevenson, COO, Thermo Fisher Scientific
Alan Wright, CMO, Roche Diagnostics
Moderator: Lea Hachigian, President, VirScan; Principal, Longwood Fund
2:00 pm
Partnering to Accelerate the Fight Against COVID-19
Mikael Dolsten, CSO & President, Worldwide Research, Development & Medical, Pfizer
Dean Li, SVP, Discovery Sciences & Translational Medicine, Merck
John Reed, EVP, Global Head, R&D, Sanofi
David Ricks, CEO, Eli Lilly
Phil Sharp, Co-Founder, Biogen/Alnylam; Nobelist, NAS
Rupert Vessey, President, Research and Early Development, Bristol-Myers Squibb
Moderator: Christoph Westphal, General Partner, Longwood Fund
2:45 pm
Financing Innovation
Mike Ehlers, CSO, Apple Tree Partners
Jason Fuller, Principal, NEA
Jak Knowles, VP, Venture Investments, Bayer
Kyle Lefkoff, General Partner, Boulder Ventures
David Steinberg, General Partner, Longwood Fund
Moderator: Lea Hachigian, Principal, Longwood Fund
3:30 pm
Longwood Discussion
Christoph Westphal, General Partner, Longwood Fund
Rich Aldrich, General Partner, Longwood Fund
David Steinberg, General Partner, Longwood Fund
John Lawrence, CFO, Longwood Fund
April 6, 2020